Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Alexandra R, Sowa"'
Autor:
Isaac M. Jackson, So Jeong Lee, Alexandra R. Sowa, Melissa E. Rodnick, Laura Bruton, Mara Clark, Sean Preshlock, Jill Rothley, Virginia E. Rogers, Leslie E. Botti, Bradford D. Henderson, Brian G. Hockley, Jovany Torres, David M. Raffel, Allen F. Brooks, Kirk A. Frey, Michael R. Kilbourn, Robert A. Koeppe, Xia Shao, Peter J. H. Scott
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 5, Iss 1, Pp 1-16 (2020)
Abstract Background In the US, EU and elsewhere, basic clinical research studies with positron emission tomography (PET) radiotracers that are generally recognized as safe and effective (GRASE) can often be conducted under institutional approval. For
Externí odkaz:
https://doaj.org/article/cd57538b10e34b189e02a014a3f2f28a
Autor:
Alexandra R Sowa, Isaac M Jackson, Timothy J Desmond, Jeremiah Alicea, Anthony J Mufarreh, Jonathan M Pham, Jenelle Stauff, Wade P Winton, Maria V Fawaz, Bradford D Henderson, Brian G Hockley, Virginia E Rogers, Robert A Koeppe, Peter J H Scott
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 3, Iss 1, Pp 1-12 (2018)
Abstract Background We recently upgraded our [18F]fludeoxyglucose (FDG) production capabilities with the goal of futureproofing our FDG clinical supply, expanding the number of batches of FDG we can manufacture each day, and improving patient through
Externí odkaz:
https://doaj.org/article/d4194efd40004f9896b141bb8eb5974e
Publikováno v:
Current Radiopharmaceuticals. 15:96-103
Background: The recent approval of radiopharmaceuticals for diagnosis and treatment of cancer is ushering nuclear medicine into a new era of theranostics and alpha therapy using radiopharmaceuticals labeled with 225Ac shows remarkable results in clin
Autor:
Peter J. H. Scott, Robert A. Koeppe, Xia Shao, Melissa E. Rodnick, Alexandra R. Sowa, Bradford D. Henderson, Jenelle Stauff, Phillip S. Sherman, Janna Arteaga, Dennis J. Carlo, Ronald B. Moss
Publikováno v:
Molecules, Vol 25, Iss 6, p 1360 (2020)
Naloxone (NLX) is a mu receptor antagonist used to treat acute opioid overdoses. Currently approved doses of naloxone to treat opioid overdoses are 4 mg intranasal (IN) and 2 mg intramuscular (IM). However, higher mu receptor occupancy (RO) may be re
Externí odkaz:
https://doaj.org/article/b3a836162887410ab4c332680f99c287
Autor:
Andrew V. Mossine, Sean S. Tanzey, Alexandra R. Sowa, Jovany Torres, Melanie S. Sanford, Peter Scott, Allen F. Brooks
Publikováno v:
Analytical Methods. 12:5004-5009
When utilizing [18F]tetrabutylammonium fluoride ([18F]TBAF) in the synthesis of 18F-labeled radiotracers for clinical positron emission tomography (PET) imaging, it is necessary to confirm that residual TBA levels in formulated doses do not exceed es
Autor:
Prabesh Kanel, Martijn L.T.M. Müller, Hailey K Gross, Nicolaas I. Bohnen, Michael R. Kilbourn, Peter J. H. Scott, Alexandra R. Sowa Dumond, Robert A. Koeppe
Publikováno v:
ACS chemical neuroscience. 12(9)
Since the earliest days of nuclear medicine, there has been interest in using PET and SPECT imaging to interrogate and quantify the cholinergic system. In this Viewpoint we highlight key milestones in the development of cholinergic imaging agents, in
Autor:
Sean S, Tanzey, Andrew V, Mossine, Alexandra R, Sowa, Jovany, Torres, Allen F, Brooks, Melanie S, Sanford, Peter J H, Scott
Publikováno v:
Analytical methods : advancing methods and applications. 12(41)
When utilizing [
Autor:
Peter Scott, Allen F. Brooks, Jonathan M. Pham, Emily Murrell, Alexandra R. Sowa, Michael R. Kilbourn, Neil Vasdev
Publikováno v:
ACS Chem Neurosci
Advances in drug discovery and diverse radiochemical methodologies have led the discovery of novel positron emission tomography (PET) radiotracers to image the GABAergic system, and have been used to shape our fundamental understanding of a variety o
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bradford D. Henderson, Phillip S. Sherman, Robert A. Koeppe, Janna Arteaga, Xia Shao, Jenelle Stauff, Peter J. H. Scott, Melissa E. Rodnick, Alexandra R. Sowa, Ronald B. Moss, Dennis J. Carlo
Publikováno v:
Molecules
Molecules, Vol 25, Iss 6, p 1360 (2020)
Volume 25
Issue 6
Molecules, Vol 25, Iss 6, p 1360 (2020)
Volume 25
Issue 6
Naloxone (NLX) is a mu receptor antagonist used to treat acute opioid overdoses. Currently approved doses of naloxone to treat opioid overdoses are 4 mg intranasal (IN) and 2 mg intramuscular (IM). However, higher mu receptor occupancy (RO) may be re